[Vasopeptidase inhibitors: new pharmacologic classes, new therapeutic opportunities].
Morganti
A
A
Centro di Fisiologia Clinica e Ipertensione Ospedale Policlinico, IRCCS Via Francesco Sforza, 35, 20122 Milano. zanchett@mailserver.unimi.it
D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D009320:Atrial Natriuretic Factor / Q000037:antagonists & inhibitors*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use; D013841:Thiazepines / Q000627:therapeutic use
D000959:Antihypertensive Agents; D011480:Protease Inhibitors; D011725:Pyridines; D013841:Thiazepines; C106266:omapatrilat; D009320:Atrial Natriuretic Factor